Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

EURO-STIM Registry

Longitudinal Outcomes and Adherence of the Inspire System, EURO-STIM Registry

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The registry is to measure longitudinal outcomes and adherence of the Inspire System. The goal of the registry is to capture the life cycle of the patient's use of the Inspire System through routine clinical care visits. There are no required interventions or testing.

Who May Be Eligible (Plain English)

Who May Qualify: Any patient implanted with or receiving an Inspire implant, who meets the following criteria, is eligible to participate in the registry: 1. Capable of giving willing to sign a consent form, as required per institution 2. Willing to return for routine clinic visits as required for Inspire therapy management Who Should NOT Join This Trial: Any patient who meets any of the following criteria will not be eligible to participate in the registry: 1. Has a life expectancy of less than one year 2. Any reason the clinician deems patient is unfit for participation in the study Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: Any patient implanted with or receiving an Inspire implant, who meets the following criteria, is eligible to participate in the registry: 1. Capable of giving informed consent, as required per institution 2. Willing to return for routine clinic visits as required for Inspire therapy management Exclusion Criteria: Any patient who meets any of the following criteria will not be eligible to participate in the registry: 1. Has a life expectancy of less than one year 2. Any reason the clinician deems patient is unfit for participation in the study

Treatments Being Tested

DEVICE

Inspire UAS System

Participants will be implanted with the Inspire UAS System, which is a permanent, implantable therapy that consists of three implantable components: an IPG, a stimulation lead, and a sensing lead. In addition, the study subject receives a remote control to activate the therapy.

Locations (20)

Klinikum Klagenfurt, KABEG
Klagenfurt, Austria
Ordensklinikum Linz
Linz, Austria
Universitair Ziekenhuis Antwerpen
Edegem, Belgium
Angers University Hospital Center
Angers, France
CHU Grenoble Alpes
La Tronche, France
Clinique de la Louviere
Lille, France
Hôpital d'Instruction des Armées Laveran
Marseille, France
Clinique Beausoleil
Montpellier, France
CHU Saint Etienne
Saint-Priest-en-Jarez, France
Asklepios Klinik Hamburg
Hamburg, Germany
Universitatsklinikum Hamburg Eppendorf
Hamburg, Germany
Klinik für HNO-Heilkunde/HNO-Schlaflabor
Lübeck, Germany
Otto-von-Guericke-Universität Magdeburg
Magdeburg, Germany
Universitäts-HNO-Klinik Mannheim
Mannheim, Germany
Klinikum Rechts der Isar Technische Universität München
Munich, Germany
Sint Lucas Andreas Ziekenhus (OLVG)
Amsterdam, Netherlands
St. Antonius Ziekenhuis Nieuwegein
Nieuwegein, Netherlands
Kantonnspital Baselland-Liestal
Liestal, Switzerland
Guy's & St Thomas' NHS Foundation Trust
London, United Kingdom
University College London Hospitals NHS Foundation Trust
London, United Kingdom